Article
High expression of DNAJA1 (HDJ2) predicts unfavorable survival outcomes in breast cancer.
Biomarkers in medicine - 1 Aug 2021
Ileri Furkan Celebi, Acun Tolga
Abstract excerpt
Aim:DNAJA1 is associated with several cancers, but its biomarker potential in breast cancer is not adequately known. Materials & methods: Q-RT-PCR, immunohistochemistry, COBRA methods and in silico tools (KM-Plotter, UALCAN) were used to analyze the expression level, methylation status and prognostic value of DNAJA1 in breast cancer. Results:DNAJA1 expression was significantly higher in clinical tumor samples...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
